$EXPO
EXPONENT INC

2022 Q2 Form 10-Q Financial Statement

#000156459022018600 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $128.5M $116.5M
YoY Change 10.3% 9.94%
Cost Of Revenue $10.61M $6.900M
YoY Change 53.74% 11.29%
Gross Profit $117.9M $109.6M
YoY Change 7.55% 9.93%
Gross Profit Margin 91.74% 94.09%
Selling, General & Admin $74.76M $77.80M
YoY Change -3.91% 34.84%
% of Gross Profit 63.42% 70.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.689M $1.700M
YoY Change -0.65% -5.56%
% of Gross Profit 1.43% 1.55%
Operating Expenses $91.76M $92.42M
YoY Change -0.72% 32.1%
Operating Profit $36.72M $24.06M
YoY Change 52.62% -33.15%
Interest Expense $21.00K $0.00
YoY Change -100.0%
% of Operating Profit 0.06% 0.0%
Other Income/Expense, Net -$3.910M $6.068M
YoY Change -164.44% -150.85%
Pretax Income $32.81M $30.13M
YoY Change 8.9% 25.24%
Income Tax $3.198M -$722.0K
% Of Pretax Income 9.75% -2.4%
Net Earnings $29.61M $30.85M
YoY Change -4.02% 17.37%
Net Earnings / Revenue 23.05% 26.48%
Basic Earnings Per Share $0.56 $0.59
Diluted Earnings Per Share $0.56 $0.58
COMMON SHARES
Basic Shares Outstanding 52.42M 52.54M
Diluted Shares Outstanding 53.04M 53.33M

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.1M $214.5M
YoY Change 0.26% 41.12%
Cash & Equivalents $215.1M $184.5M
Short-Term Investments $30.00M
Other Short-Term Assets $14.13M $14.80M
YoY Change -4.51% 4.96%
Inventory
Prepaid Expenses
Receivables $147.5M $124.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $376.7M $353.6M
YoY Change 6.53% 20.52%
LONG-TERM ASSETS
Property, Plant & Equipment $61.08M $78.90M
YoY Change -22.59% -4.13%
Goodwill $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.519M $135.9M
YoY Change -98.88% 36.86%
Total Long-Term Assets $240.9M $223.4M
YoY Change 7.81% 17.39%
TOTAL ASSETS
Total Short-Term Assets $376.7M $353.6M
Total Long-Term Assets $240.9M $223.4M
Total Assets $617.5M $577.0M
YoY Change 7.03% 19.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.84M $18.40M
YoY Change 67.61% 31.43%
Accrued Expenses $62.60M $60.60M
YoY Change 3.3% 17.9%
Deferred Revenue $15.67M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $109.1M $87.90M
YoY Change 24.13% 14.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $121.9M $111.5M
YoY Change 9.3% 34.18%
Total Long-Term Liabilities $121.9M $111.5M
YoY Change 9.3% 34.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.1M $87.90M
Total Long-Term Liabilities $121.9M $111.5M
Total Liabilities $231.0M $199.4M
YoY Change 15.84% 24.47%
SHAREHOLDERS EQUITY
Retained Earnings $493.4M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $398.5M
YoY Change
Treasury Stock Shares $13.89M
Shareholders Equity $386.6M $377.6M
YoY Change
Total Liabilities & Shareholders Equity $617.5M $577.0M
YoY Change 7.03% 19.29%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income $29.61M $30.85M
YoY Change -4.02% 17.37%
Depreciation, Depletion And Amortization $1.689M $1.700M
YoY Change -0.65% -5.56%
Cash From Operating Activities -$6.352M $1.285M
YoY Change -594.32% -109.29%
INVESTING ACTIVITIES
Capital Expenditures $2.606M $2.515M
YoY Change 3.62% 94.51%
Acquisitions
YoY Change
Other Investing Activities $0.00 $15.00M
YoY Change -100.0% 66.67%
Cash From Investing Activities -$2.606M $12.49M
YoY Change -120.87% 62.03%
FINANCING ACTIVITIES
Cash Dividend Paid $12.51M $11.94M
YoY Change 4.85% 15.78%
Common Stock Issuance & Retirement, Net $48.55M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -73.41M -27.03M
YoY Change 171.62% -57.98%
NET CHANGE
Cash From Operating Activities -6.352M 1.285M
Cash From Investing Activities -2.606M 12.49M
Cash From Financing Activities -73.41M -27.03M
Net Change In Cash -82.64M -13.00M
YoY Change 535.47% -81.64%
FREE CASH FLOW
Cash From Operating Activities -$6.352M $1.285M
Capital Expenditures $2.606M $2.515M
Free Cash Flow -$8.958M -$1.230M
YoY Change 628.29% -91.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4899000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
147508000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14133000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
376691000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61077000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16898000
CY2022Q2 us-gaap Goodwill
Goodwill
8607000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46501000
CY2022Q2 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
106255000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1519000
CY2022Q2 us-gaap Assets
Assets
617548000
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
30840000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
57291000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15669000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5310000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11654000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36717000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24058000
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
21000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
29000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3931000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6039000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3910000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6068000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53039000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53333000
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29609000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
30848000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-310000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
243000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2293000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1983000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
493387000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
478370000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13885000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13591000
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
398485000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
340807000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
386564000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
617548000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
683739000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128478000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116481000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
68757000
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
74538000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8165000
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7710000
CY2022Q2 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
10608000
CY2021Q2 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
6902000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4231000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3273000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
91761000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
92423000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32807000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30126000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3198000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-722000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29609000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
30848000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52419000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52536000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29299000
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
645000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6870000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6282000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
45000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1226000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8333000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31087000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
564000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4094000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48554000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-310000
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
CY2022Q2 us-gaap Dividends
Dividends
13200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29609000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
386564000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
543000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3738000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
243000
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7637000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15634000
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4000
CY2021Q2 us-gaap Dividends
Dividends
11261000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
30848000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
377608000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
29609000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
30848000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1689000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1656000
CY2021Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
7000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
686000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13291000
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9948000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8142000
CY2022Q2 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
535000
CY2021Q2 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
627000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5234000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3451000
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-27576000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-17862000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4093000
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2894000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6352000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1285000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2606000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2515000
CY2021Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9997000
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
25000000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2606000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12488000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15634000
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48554000
CY2022Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
564000
CY2021Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
543000
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
12514000
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
11935000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73408000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27026000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-271000
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82637000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13004000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197525000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215050000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184521000
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:5.56%;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates. <span style="font-weight:normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates. </span></p>
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9644000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6015000
CY2022Q2 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
3660000
CY2021Q2 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
3644000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
166535000
CY2022Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116260000
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
116260000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
210923000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
110379000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52419000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52536000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53039000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53333000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18742
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
114953000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
109342000
CY2022Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116260000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2022Q2 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-4699000
CY2021Q2 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
5579000
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
852000
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
381000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000
CY2022Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
CY2021Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7637000
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
602000
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
393000
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4011000
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
573000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4899000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
147508000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4423000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
686000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
210000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4899000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128478000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116481000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36717000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24058000
CY2022Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2795000
CY2021Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2306000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1689000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1656000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2201000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2279000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4010000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4904000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3217000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2427000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2446000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1937000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18941000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1977000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
16964000

Files In Submission

Name View Source Status
0001564590-22-018600-index-headers.html Edgar Link pending
0001564590-22-018600-index.html Edgar Link pending
0001564590-22-018600.txt Edgar Link pending
0001564590-22-018600-xbrl.zip Edgar Link pending
expo-10q_20220401.htm Edgar Link pending
expo-10q_20220401_htm.xml Edgar Link completed
expo-20220401.xsd Edgar Link pending
expo-20220401_cal.xml Edgar Link unprocessable
expo-20220401_def.xml Edgar Link unprocessable
expo-20220401_lab.xml Edgar Link unprocessable
expo-20220401_pre.xml Edgar Link unprocessable
expo-ex311_8.htm Edgar Link pending
expo-ex312_9.htm Edgar Link pending
expo-ex321_7.htm Edgar Link pending
expo-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending